Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Safety and efficacy study of SANGUINATE on reduction of delayed graft function (DGF) in
patients who will be recipients of a donation after brain death (DBD) donor kidney.